June 09, 2020
2 min watch
Save
VIDEO: EDOF IOL performs well in clinical trials
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
John A. Hovanesian, MD, FACS, discusses visual results in patients implanted with the SC9 extended depth of focus IOL developed by CORD from the virtual American Society of Cataract and Refractive Surgery meeting.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Hovanesian reports he is a paid investigator for CORD.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.